Literature DB >> 12887925

Telomerase maintains telomere structure in normal human cells.

Kenkichi Masutomi1, Evan Y Yu, Shilagardy Khurts, Ittai Ben-Porath, Jennifer L Currier, Geoffrey B Metz, Mary W Brooks, Shuichi Kaneko, Seishi Murakami, James A DeCaprio, Robert A Weinberg, Sheila A Stewart, William C Hahn.   

Abstract

In normal human cells, telomeres shorten with successive rounds of cell division, and immortalization correlates with stabilization of telomere length. These observations suggest that human cancer cells achieve immortalization in large part through the illegitimate activation of telomerase expression. Here, we demonstrate that the rate-limiting telomerase catalytic subunit hTERT is expressed in cycling primary presenescent human fibroblasts, previously believed to lack hTERT expression and telomerase activity. Disruption of telomerase activity in normal human cells slows cell proliferation, restricts cell lifespan, and alters the maintenance of the 3' single-stranded telomeric overhang without changing the rate of overall telomere shortening. Together, these observations support the view that telomerase and telomere structure are dynamically regulated in normal human cells and that telomere length alone is unlikely to trigger entry into replicative senescence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887925     DOI: 10.1016/s0092-8674(03)00550-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  180 in total

Review 1.  When cells get stressed: an integrative view of cellular senescence.

Authors:  Ittai Ben-Porath; Robert A Weinberg
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 2.  Do tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence?

Authors:  Pier Giuseppe Pelicci
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

3.  Does a sentinel or a subset of short telomeres determine replicative senescence?

Authors:  Ying Zou; Agnel Sfeir; Sergei M Gryaznov; Jerry W Shay; Woodring E Wright
Journal:  Mol Biol Cell       Date:  2004-06-04       Impact factor: 4.138

4.  Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling.

Authors:  A Satyanarayana; R A Greenberg; S Schaetzlein; J Buer; K Masutomi; W C Hahn; S Zimmermann; U Martens; M P Manns; K L Rudolph
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

5.  Relationship between microvessel density and telomerase activity in hepatocellular carcinoma.

Authors:  Yun-Feng Piao; Min He; Yang Shi; Tong-Yu Tang
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

6.  Small-molecule-based identification of dynamic assembly of E2F-pocket protein-histone deacetylase complex for telomerase regulation in human cells.

Authors:  Jaejoon Won; Seungwoo Chang; Sangtaek Oh; Tae Kook Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

Review 7.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

8.  Telomerase inhibitor PinX1 provides a link between TRF1 and telomerase to prevent telomere elongation.

Authors:  Christina Y Soohoo; Rong Shi; Tae Ho Lee; Pengyu Huang; Kun Ping Lu; Xiao Zhen Zhou
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

9.  Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT.

Authors:  Alexander Röth; Gabriela M Baerlocher; Mike Schertzer; Elizabeth Chavez; Ulrich Dührsen; Peter M Lansdorp
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

10.  Involvement of telomerase reverse transcriptase in heterochromatin maintenance.

Authors:  Yoshiko Maida; Mami Yasukawa; Naoko Okamoto; Seii Ohka; Keita Kinoshita; Yasushi Totoki; Takashi K Ito; Tohru Minamino; Hiromi Nakamura; Satoko Yamaguchi; Tatsuhiro Shibata; Kenkichi Masutomi
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.